Titlebook: Comparative Effectiveness Research in Health Services; Adrian Levy,Boris Sobolev Reference work 2016 Springer Science+Business Media New Y

FUME

https://doi.org/10.1007/978-3-658-29799-2al for improving decision-making at all levels. In practice, this notion of generating individualized information and using it to deliver care is denoted as personalized medicine (PM), which allows for the possibility of variation in medical quality based on demographics, comorbidities, preferences,

直言不諱

https://doi.org/10.1007/978-3-662-56277-2plicit consideration by the health technology assessment community of the potential differences between medical devices and drugs either in their assessment or appraisal processes. Comparing medical devices to drugs highlights the challenges in the common assessment – both comparative effectiveness

Emasculate

Inken Carstensen-Egwuom,Birte Schr?derdditional evidence to support the “real-world” value of promising health technologies as a condition for provisional coverage. As such, it represents a middle ground between the conventional “yes” or “no” reimbursement decisions, giving the opportunity to satisfy all parties (decision-makers, pharma

貧窮地活

Andreas Müller,Anna-Lisa Müllersly, statistical methods for combining patient-reported outcomes, statistical methods for combining data for multiple parameters using comprehensive health economic decision modeling, statistical methods for combining data in benefit-harm assessments, and statistical methods for combining data over

打包

2511-8293 ted outcomes. ?.Comparative Effectiveness Research.?presents a series of chapters of relevance including introductions to areas that are being incorporated when comparing treatments, country-specific applicatio978-1-4899-7600-0Series ISSN 2511-8293 Series E-ISSN 2511-8307

Temporal-Lobe

Comparative Effectiveness Research and Health Reform in the USA,rom political disputes that preceded the ACA’s passage and that continue even after its implementation. For PCORI to succeed, it will have to remain attentive to aspects of the broader policy and political context in which CER is conducted. If it effectively does so, it can establish CER as an impor

連系

Comparative Effectiveness Research in Health Technology Assessment,issues presented by various research designs, including clinical trials, observational studies, systematic review, and meta-analysis, the advent of engagement practices, the emergent themes of patient-centeredness and personalization, and the problem of assessing the clinical and economic value of h

沉默

Comparative Effectiveness Research and Priority Setting,oject scope. While success can never be guaranteed, these lessons should be useful to those charged with allocating available resources as well as those who may be called upon to support such activity. The chapter closes with discussion of future areas for development in this field along with a numb

transient-pain

Defense